Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance" [Crit. Rev. Oncol./Hematol. 164 (2021) 1-11/103424].
Muraro E, Fanetti G, Lupato V, Giacomarra V, Steffan A, Gobitti C, Vaccher E, Franchin G. Muraro E, et al. Among authors: gobitti c. Crit Rev Oncol Hematol. 2021 Oct;166:103479. doi: 10.1016/j.critrevonc.2021.103479. Epub 2021 Sep 17. Crit Rev Oncol Hematol. 2021. PMID: 34544612 No abstract available.
Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.
Fanetti G, Polesel J, Fratta E, Muraro E, Lupato V, Alfieri S, Gobitti C, Minatel E, Matrone F, Caroli A, Revelant A, Lionello M, Zammattio Polentin V, Ferretti A, Guerrieri R, Chiovati P, Bertolin A, Giacomarra V, Paoli A, Vaccher E, Sartor G, Steffan A, Franchin G. Fanetti G, et al. Among authors: gobitti c. Nutrients. 2021 Apr 13;13(4):1277. doi: 10.3390/nu13041277. Nutrients. 2021. PMID: 33924581 Free PMC article.
Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
Franchin G, Vaccher E, Gobitti C, Minatel E, Politi D, Talamini R, Di Gennaro G, Savignano G, Trovò MG, Tirelli U, Barzan L. Franchin G, et al. Among authors: gobitti c. Oral Oncol. 2005 May;41(5):526-33. doi: 10.1016/j.oraloncology.2004.12.013. Epub 2005 Apr 9. Oral Oncol. 2005. PMID: 15878759 Clinical Trial.
Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer.
Fanetti G, Alterio D, Marvaso G, Gandini S, Rojas DP, Gobitti C, Minatel E, Revelant A, Caroli A, Francia CM, Alessandro O, Pepa M, Gugliandolo SG, Starzyńska A, Polesel J, Vaccher E, Cossu Rocca M, Tagliabue M, Ansarin M, Lupato V, Giacomarra V, De Paoli A, Orecchia R, Franchin G, Jereczek-Fossa BA. Fanetti G, et al. Among authors: gobitti c. Oral Dis. 2020 Oct;26(7):1384-1392. doi: 10.1111/odi.13366. Epub 2020 May 13. Oral Dis. 2020. PMID: 32315470
Predictive Value of CD8 Expression and FoxP3 Methylation in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy in a Non-endemic Area.
Muraro E, Vaccher E, Furlan C, Fratta E, Fanetti G, Fae' DA, Martorelli D, Cangemi M, Polesel J, Navarria F, Gobitti C, Comaro E, Scaini C, Pratesi C, Zanussi S, Lupato V, Grando G, Giacomarra V, Sulfaro S, Barzan L, Dolcetti R, Steffan A, Canzonieri V, Franchin G. Muraro E, et al. Among authors: gobitti c. Pathol Oncol Res. 2020 Oct;26(4):2459-2467. doi: 10.1007/s12253-020-00859-3. Epub 2020 Jun 21. Pathol Oncol Res. 2020. PMID: 32564263 Free article.
62 results